An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia

Stem Cell Res. 2021 May:53:102322. doi: 10.1016/j.scr.2021.102322. Epub 2021 Apr 5.

Abstract

Achondroplasia (ACH; MIM #100800) is an autosomal dominant genetic disease caused by gain-of-function mutations in FGFR3 gene and results in short-limb dwarfism. Here, we generated an induced pluripotent stem cell line GZHMCi004-A derived from umbilical cord blood mononuclear cells (UCBMCs) of a fetus with heterozygous G380R mutation in FGFR3 gene. This iPSC line is a valuable in vitro model to study the pathological mechanism and the treatment of ACH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Achondroplasia* / genetics
  • Fetus
  • Humans
  • Induced Pluripotent Stem Cells*
  • Mutation
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3